The World Health Organisation (WHO) issued an alert over three "substandard" cough syrups found in India, including Coldrif, Respifresh TR, and ReLife. It has called on regulatory authorities across the globe to report immediately if any of these products are discovered in their countries. This follows the deaths of 22 children in Madhya Pradesh, most of them under the age of five, due to suspected kidney failure after being administered Coldrif.

The WHO urged heightened vigilance and monitoring within the supply chains of countries and regions that may be at risk from these substandard medicines. As per a report by PTI , it stated, “Increased surveillance of the informal/unregulated market is also advised.” Also Read | Cough syrup deaths: All about the medicines declared toxic by

See Full Page